Simpler Grants.gov #PAR-24-295

NIH Emerging Global Leader Award (K43) Grant for Independent Clinical Trials in LMICs

The National Institutes of Health (NIH) is seeking applications for the Emerging Global Leader Award (K43), which requires the conduct of an independent clinical trial. - Government Buyer: - National Institutes of Health (NIH) - Eligible Applicants: - Academic education or research institutions located in low- or middle-income countries (LMICs) as defined by the World Bank - Products/Services Requested: - Grant funding for independent clinical trial research in a broad range of health and disease areas, including: - Deafness and communication disorders - Sleep disorders - Neurosciences - Cardiovascular, heart, lung, and blood diseases - Environmental health - Aging - Human genome research - Cancer research manpower - Women's health - Mental health - International research and training - Blood diseases - Drug abuse and addiction - Unique or Notable Requirements: - No specific OEMs or vendors are involved; this is a research grant, not a product procurement - No cost sharing or matching required - Funding instrument is a grant - Eligibility restricted to non-U.S. entities in LMICs - Research must align with NIH clinical trials policy

Description

This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy. The program is a grant opportunity provided by the National Institutes of Health targeting research related to various health and disease areas. Eligible applicants include academic education or research institutions in low- or middle-income countries as defined by the World Bank. The funding instrument type is a grant, and there is no cost sharing or matching requirement specified.

View original listing